- Tipo NewsRISULTATO
- FonteVarie - UE
- Del
La Joint Transnational Call (JTC) 2023 del partenariato TRANSCAN-3 ha selezionjato 13 progetti vincitori che riceveranno quasi 17 milioni per lo studio dell'epigenetica del cancro.
I progetti, scelti per la loro innovatività ed eccellenza, promettono di apportare significativi contributi nel campo della ricerca sul cancro, portando a scoperte nel campo di diagnosi, trattamento e prevenzione del cancro. Di seguito è riportato l'elenco dei progetti selezionati:
- DC2M-TAEC - Detection, Classification, Characterization and Treatment Monitoring of Tumors by Accessible Epigenetic Classification
- DICE - Epigenomic regulation of cancer immunity by dietary intervention
- EPI_T-ALL - Unveiling the Epigenetic Landscape and Therapeutic Implications of Epigenetic Modifiers in Human T-cell Leukemia Initiation and Progression
- EPILUCAFS - Chronic stress and immunosuppression in lung cancer: focus on epigenetic drivers in cancer-associated fibroblasts
- EPILUNAR - Epigenomic Profiling of Liquid Biopsy and Immunotherapy Resistance in Lung Cancer
- EpiNanSarc - Sarcoma subtyping and stratification using genome-wide epigenetic profiling
- EPIPROPER - Identifying EPIgenetic determinants and biomarkers of drug resistance via characterization of PROspective PERsister cells
- EXPLORE-NB - Exploring the epigenetic neuroblastoma landscape to improve measurable disease monitoring, disease understanding and personalized treatment
- HYDRA - Charting the epigenomic trajectory of progression towards metastatic colorectal cancer
- REACH - Reversing Epitranscriptomic Alterations for CHemosensitization of Pancreatic Cancer
- REACTION - Deciphering Epigenetic Biomarkers to Identify Preleukemic Carriers at Risk
- SCIE-PANC - Stromal Compartment and Immune Epigenome spatial networks to counter therapy evasion in PANcreatic Cancer
- SPELCASTER - Standardized Profiling of Epigenetic Loci for decentralized ClAssification of Sinonasal Tumors and idEntification of therapy Response markers